Rachel Logan, Photo courtesy of Logan

Rachel G. Logan

PhD Candidate in Public Health, University of South Florida
Chapter Member: Florida SSN
Areas of Expertise:

Connect with Rachel

About Rachel

Logan is a fifth-year doctoral candidate and graduate research/teaching associate at the University of South Florida. Her research interests include sexual health disparities and sexual health communication particularly among low-income and marginalized populations. Current work involves research on sexual health communication between patients and providers and a quality improvement initiative regarding providing pregnant and postpartum women with comprehensive options for contraception. Her work aims to center the experiences of women of color and other marginalized populations.

In the News

Interview on reproductive justice Rachel G. Logan, University of South Florida College of Public Health, March 2, 2018.
"Fight the Spread of HIV," Rachel G. Logan, Tampa Bay Times, November 20, 2015.


"Sexually Transmitted Infection Prevention with Long-Acting Reversible Contraception: Factors Associated with Dual Use" (with Erika L. Thompson, Cheryl A. Vamos, Stacey B. Griner, Coralia Vázquez-Otero, and Ellen M. Daley). Sexually Transmitted Diseases 44, no. 7 (2017): 423–427.

Discusses how long-acting reversible contraception (LARC) is recommended as a first-line defense mechanism to assist women in reducing risk of unintended pregnancy. Explores how lesser-known dual use, concurrent LARC and condom use during sexual activity, reduces the risk of pregnancy and sexually transmitted infections. Examines dual method use among college women.


"Perceptions of Zika Virus Prevention among College Students in Florida" (with Erika L. Thompson, Cheryl A. Vamos, Julianna Jones, Langdon G. Liggett, Stacey B. Griner, and Ellen M. Daley). Journal of Community Health 43, no. 4 (2018): 673–679.

Discusses how the presence of the Zika virus in Florida prompted an investigation of college women's knowledge, perceptions about their susceptibility to Zika, and potential changes to their contraceptive use.